Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New glucose monitor put to the test in diabetes trial

NCT ID NCT05806554

First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 18 times

Summary

This study tested how well the True Vie I3 continuous glucose monitor (CGM) measures blood sugar levels in 159 adults with type 1 or type 2 diabetes. Participants wore the device while researchers compared its readings to standard lab measurements. The goal was to see if the monitor meets FDA accuracy standards for integrated CGM systems.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Atlanta Diabetes Associates

    Atlanta, Georgia, 30318, United States

  • Diablo Clinical Research

    Walnut Creek, California, 94598, United States

  • Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm

    Ulm, D-89081, Germany

  • PSHI Praxis GmbH

    Mainz, 55128, Germany

  • Rainier Clinical Research Center

    Renton, Washington, 98057, United States

  • Woodland Research Northwest

    Rogers, Arkansas, 72758, United States

Conditions

Explore the condition pages connected to this study.